Chronic cough, persisting for over eight weeks, is a common yet challenging condition encountered in clinical practice. Despite its prevalence, the multifactorial nature often leads to diagnostic uncertainty and therapeutic complexity.
Initial diagnostic efforts should focus on identifying common causes such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS) due to rhinosinus conditions. If these are excluded, consider less common etiologies, including non-asthmatic eosinophilic bronchitis, chronic bronchitis, and bronchiectasis. A systematic approach, including a detailed history, physical examination, and targeted investigations, remains paramount.
High-resolution computed tomography (HRCT) can reveal bronchiectasis, interstitial lung disease, or malignancies, while Pulmonary Function Tests (PFTs) can uncover obstructive or restrictive abnormalities. However, their routine use is not recommended, and they should be reserved for cases with unexplained symptoms or abnormal initial investigations.
Treatment should be etiology-specific and may involve lifestyle modifications, pharmacological interventions, or rarely, surgery. Empirical therapy for GERD, UACS, or asthma can be considered if the diagnosis is uncertain. Refractory cases may benefit from referral to a cough specialist or a multidisciplinary team.
Emerging research focuses on understanding the pathophysiology of chronic cough, including the role of neuronal hypersensitivity and novel therapeutic targets. However, the translation of these findings into clinical practice requires further studies.
Chronic cough poses diagnostic and therapeutic challenges in medical practice. A comprehensive and systematic approach, coupled with an understanding of common and uncommon causes, is essential for effective management. Future research promises to enhance our understanding and treatment of this complex condition.
1.
MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information
2.
Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win
3.
ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology
4.
There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.
5.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
1.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
2.
Strategic Solutions in Oncology for Modern Medicine
3.
Tumor Microenvironment Mapping in Cancer Care
4.
Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases
5.
Emerging Therapies Using Tumor Evolution Interruption Technologies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
2.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
3.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
5.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation